Bath & Body Works (NYSE:BBWI) Hits New 52-Week Low – Here’s What Happened

Bath & Body Works, Inc. (NYSE:BBWI)’s stock price hit a new 52-week low during trading on Monday . The stock traded as low as $21.47 and last traded at $21.4050, with a volume of 5835632 shares. The stock had previously closed at $22.00.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Wells Fargo & Company dropped their price target on shares of Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a research note on Monday, October 27th. Telsey Advisory Group reiterated an “outperform” rating and set a $38.00 target price on shares of Bath & Body Works in a research report on Thursday. Morgan Stanley increased their price target on Bath & Body Works from $40.00 to $43.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, October 8th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $26.00 price objective on shares of Bath & Body Works in a report on Monday, October 6th. Ten research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, Bath & Body Works has an average rating of “Moderate Buy” and a consensus price target of $38.18.

Bath & Body Works Trading Down 2.3%

The firm’s fifty day moving average price is $25.50 and its 200-day moving average price is $28.52. The company has a market cap of $4.43 billion, a price-to-earnings ratio of 6.38, a price-to-earnings-growth ratio of 0.86 and a beta of 1.53.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, hitting the consensus estimate of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same period in the previous year, the company posted $0.37 earnings per share. The company’s revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, research analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 3.7%. The ex-dividend date is Friday, November 21st. Bath & Body Works’s dividend payout ratio (DPR) is 23.74%.

Institutional Investors Weigh In On Bath & Body Works

Several large investors have recently made changes to their positions in BBWI. T. Rowe Price Investment Management Inc. lifted its position in Bath & Body Works by 7.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock valued at $334,029,000 after acquiring an additional 781,681 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Bath & Body Works by 11.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock valued at $212,120,000 after purchasing an additional 733,000 shares during the period. Alliancebernstein L.P. lifted its holdings in shares of Bath & Body Works by 2.2% in the third quarter. Alliancebernstein L.P. now owns 5,861,444 shares of the company’s stock valued at $150,991,000 after purchasing an additional 123,648 shares in the last quarter. Cooper Creek Partners Management LLC lifted its holdings in shares of Bath & Body Works by 42.7% in the second quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock valued at $162,081,000 after purchasing an additional 1,619,276 shares in the last quarter. Finally, American Century Companies Inc. boosted its position in shares of Bath & Body Works by 2,204.1% during the third quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock worth $133,292,000 after buying an additional 4,949,796 shares during the period. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.